Trade ARCT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Arcturus Therapeutics Holdings Inc. (ARCT) is trading at US$14.74, down 5.69% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$382.29M. Over the past 52 weeks, ARCT has traded between US$5.50 and US$24.17. On Syfe you can trade ARCT with $0 commission and add it to your watchlist.
| Previous close | US$15.63 |
|---|---|
| Market cap | US$382.29M |
| 52-week range | US$5.50 – US$24.17 |
| Volume | 720.71K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Year: 2013
Arcturus Therapeutics, Thermo Fisher Scientific to Collaborate on Advancing ARCT-032 in Cystic Fibrosis
Jul 2, 11:33 AM · MT Newswires
Arcturus Therapeutics Holdings Inc. (ARCT) stock is trading at US$14.74, -5.69% from the previous close of US$15.63.
The market cap for Arcturus Therapeutics Holdings Inc. (ARCT) stock is approximately US$382.29M.
The 52-week high for Arcturus Therapeutics Holdings Inc. (ARCT) stock is US$24.17.
The 52-week low for Arcturus Therapeutics Holdings Inc. (ARCT) stock is US$5.50.
Arcturus Therapeutics Holdings Inc. (ARCT) does not currently pay a dividend.
Stay on top of ARCT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
